Lumbar StenosisNCT06052579
Comparison Of A Novel Hand-held Retractor-Assisted Transforaminal Lumbar Interbody Fusion By The Wiltse Approach And Posterior TLIF
A study testing new hand-held retractor systems-assisted WiltseTLIF surgery in people with Lumbar Stenosis and Spondylolisthesis, run by Nanfang Hospital, Southern Medical University at 1 site in China.
Trial summary
In recent years, hand-held retractors have been applied to assist in Wiltse approach to perform canal decompression, causing less paraspinal muscle injury and yielding better postoperative clinical outcomes than P-TLIF. Read more about this study
- Who is it for?
- Ages 20 to 70 years
- Conditions the study is for
- Lumbar Stenosis, Spondylolisthesis
- What is being tested?
- new hand-held retractor systems-assisted WiltseTLIF surgery
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteChina
- Study dates
- 1 Jan 2019to 30 Jun 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- patients underwent either one or two-level spinal fusion surgery due to lumbar stenosis, grade 1 or 2 spondylolisthesis, or lumbar disc herniation with lumbar instability and mechanical lower back pain
Who cannot join
- Patients with lumbar infection (i), spinal tumor (ii), severe osteoporosis (iii), pregnant and lactating women (iv), severe lumbar stenosis (v), and severe comorbidities (vi)
Trial locations and contacts
1 site in 1 country.
China1 site
Division of Spinal Surgery, Department of Orthopaedics, Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510000
About this study
Official title: A Controlled Study of Articular Process Retractor Assisted- Multifidus Lateral Approach for Transforaminal Lumbar Interbody Fusion
In recent years, hand-held retractors have been applied to assist in Wiltse approach to perform canal decompression, causing less paraspinal muscle injury and yielding better postoperative clinical outcomes than P-TLIF. However, few prospective studies have been conducted comparing the clinical and radiological outcomes between Wiltse TLIF and P-TLIF, both assisted by hand-held retractors. Therefore, further research is warranted to assess whether hand-held retractor-assisted Wiltse TLIF can yield less paraspinal muscle injury and better postoperative clinical outcomes.
Read the detailed description
Study procedures How many people will participate in this study? Approximately 60 people will participate in this study conducted at the Nanfang Hospital of Southern Medical University.
Research Steps ■ Pre-study:
To determine if you are eligible to participate, the following procedures will be conducted during the screening:
Obtain your demographic and vital sign information Perform a physical examination Inquire about your medical history and concurrent medications Collect blood and urine samples for laboratory testing, imaging (X-ray, CT, MRI) If you are a fertile female, a pregnancy test will be conducted. A negative result is required for your participation in this study.
The screening results and/or results of relevant issues will help the researchers decide if you can continue with this study. If these checks indicate that you are suitable for this study, you will be informed by the researchers to proceed to visit 2 as soon as possible. If you do not meet the relevant criteria, you cannot continue to participate in this study, and the results will be communicated to you promptly.
■ Baseline Phase
If the researchers confirm that you meet the criteria for joining this trial, you will be enrolled in this study and undergo a transforaminal lumbar interbody fusion (TLIF) through either a multilevel paraspinal approach or a posterior midline approach, which will be randomly allocated (similar to drawing lots). The following procedures will be conducted during this visit:
Reconfirm your eligibility for participation Allocate you to either the multilevel paraspinal group or the posterior midline group based on randomization Conduct a physical examination and collect vital sign data Preoperative visual analog scale (VAS) score for pain, Oswestry Disability Index (ODI) score for back pain, Japanese Orthopaedic Association (JOA) score for lower back pain, and MOS 36-Item Short Form Health Survey (SF-36) quality of life score ■ Treatment Phase
During this period, the researchers will perform surgery on you based on the randomization results and assess the surgical outcomes. To ensure the accurate recording and evaluation of your condition, your cooperation is required for the following procedures:
Record postoperative drainage, time to get out of bed, discharge time, and postoperative complications Extract approximately 5ml of venous blood from you 24 hours after surgery to measure serum creatine kinase (CK) and C-reactive protein (CRP) Assess you using the VAS, ODI, JOA lower back pain score, and SF-36 quality of life score 7 days after surgery
■ Follow-up Phase
After you complete this stage of visits, it is generally considered that you have completed the entire study. The following procedures will be carried out during this period:
X-ray examination of the lumbar vertebrae in the anteroposterior and lateral views, assessment of pain, functional impairment, and quality of life score at the 3rd month after surgery X-ray and lumbar spine MRI at the 6th month after surgery, assessment of pain, functional impairment, and quality of life score X-ray and lumbar spine CT at the 1st year after surgery, assessment of pain, functional impairment, and quality of life score X-ray and lumbar spine CT at the 2nd year after surgery, assessment of pain, functional impairment, and quality of life score 3.3. What tests and assessments will be conducted in this study? After providing written informed consent, you will undergo various tests, examinations, and procedures during this study. If you have any concerns about any of these tests, please discuss them with the study doctor.
Regarding the tests and procedures for this study, we would like to provide the following information:
Medical history: The study doctor will ask you some questions to understand any current or past illnesses.
Demographic data: The study doctor will collect personal information about you, such as date of birth and ethnic background.
Physical examination: The study doctor will conduct a medical examination of your body to assess all or part of the following human body systems: head, eyes, ears, nose and throat, chest, lungs, heart, abdomen, bones, skin, neck, and nervous system.
Height and weight: Your height and weight will be measured. Vital signs: The study doctor will measure your blood pressure, heart rate, body temperature, and respiratory rate.
Blood collection: During this study, you will undergo multiple blood draws. Blood samples will be collected for the following purposes:
Preoperative blood draw: Preoperative tests (complete blood count, electrolytes, liver and kidney function, coagulation function, infection indicators), routine preoperative assessment.
Blood draw 24 hours after surgery: Approximately 5ml of venous blood will be drawn to measure serum creatine kinase (CK) and C-reactive protein (CRP).
Routine blood tests on the 3rd day after surgery: Complete blood count, ion six tests, infection two tests.
Urine samples: Routine urine tests. Pulmonary function and echocardiography if necessary. Lumbar spine anteroposterior (preoperative, 7 days after surgery, 3 months after surgery, 6 months after surgery, 1 year after surgery, 2 years after surgery), dynamic positions, oblique positions, lumbar spine MRI (preoperative and 6 months after surgery), lumbar spine CT (preoperative, 1 year after surgery, 2 years after surgery).
Questionnaire: Visual Analog Scale (VAS) score for pain, Oswestry Disability Index (ODI) score for back pain, Japanese Orthopaedic Association (JOA) score for lower back pain, and MOS 36-Item Short Form Health Survey (SF-36) quality of life score (preoperative, 7 days after surgery, 3 months after surgery, 6 months after surgery, 1 year after surgery, 2 years after surgery) How long will this study last? This clinical study will last approximately 2 years (6 visits in total). During your participation in this study, you must comply with the specified visit schedule.
You have the right to control the use and disclosure of your personal information. Where permitted by national law, you can request to view your medical information at any time. You have the right to review all information collected about you in this study and request corrections (if applicable).
New information related to the study During the study period, if there are changes in study procedures, newly discovered side effects, or significant developments that may affect your health or willingness to participate, the research team will inform you. The study doctor will notify you immediately and discuss with you whether you want to continue participating in this study. If you decide not to continue in this study, the study doctor will make arrangements for your diagnostic and therapeutic care to continue. If you choose to remain in this study, the study doctor may ask you to sign a new informed consent form.
Use of Research Results and Confidentiality of Personal Information At the end of the study, we will prepare a report and send it to the government regulatory agency. The results of this study may also be published in journals or presented at conferences, but will not contain any information that could identify you. To ensure privacy, records or samples published for research purposes will not include your name or other identifying information. Instead, your information will be identified only by a code. Only the study doctor and authorized personnel will be able to link this code to your name using a list that will be securely kept at the study center. In order to ensure that the study is conducted correctly at the study center, when necessary, the applicant, the ethics review committee, and the government regulatory authorities may review your information according to regulations. They are bound by confidentiality and will not violate your privacy.
You have the right to control the use and disclosure of your personal information. Where permitted by national law, you can request to view your medical information. You have the right to review all information collected about you in this study and request corrections (if applicable).
- Conditions
- Lumbar Stenosis, Spondylolisthesis
- Being tested
- new hand-held retractor systems-assisted WiltseTLIF surgery
- Keywords
- Wiltse approach TLIF, transforaminal lumbar interbody fusion, hand-held retractors system
- Medical subject headings
- Constriction, Pathologic, Spondylolisthesis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
new hand-held retractor systems-assisted WiltseTLIF surgeryProcedure or surgery
patients were included in study group underwent the new hand-held retractors assisted Wiltse TLIF surgery
| Study group | Role | What they receive |
|---|---|---|
| study group | Experimental | the patients included in the study group underwent Wiltse TLIF Receives: Procedure: new hand-held retractor systems-assisted WiltseTLIF surgery |
| control group | Active comparator | the patients included in the control group underwent traditional posterior -TLIF Receives: Procedure: new hand-held retractor systems-assisted WiltseTLIF surgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
the degree of paraspinal muscle degeneration
the infiltration of fat and connective tissue are mainly manifested as enhanced signals on T2-weighted imaging
Measured: 6 months postoperatively
Secondary outcomes (1)
the degree of paraspinal muscle degeneration
concentrations of the Serum creatine kinase and C reactive-protein
Measured: Preoperative,7 days, 3, 6, and 12 months after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Sep 2023
- Study start1 Jan 2019
- Primary completion1 Dec 2021
- Study completion30 Jun 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Lumbar StenosisStudies of the same condition, open and under way.
- More trials run by Nanfang Hospital, Southern Medical UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Sequential
- Model description
- This one-year prospective controlled study compared two approaches (Wiltse TLIF vs P-TLIF) for hand-held retractors-assisted TLIF was approved by the Institutional Review Board (IRB) of our hospital. Written informed consent was obtained from all study participants. 60 eligible patients were included in this study and were divided into two groups.30patientswere included in the study group and underwent Wiltse TLIF, and 30 were included in the control group and underwent P-TLIF.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Xing Shen, M.D, Principal investigator, Nanfang Hospital, Southern Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06052579
- Sponsor's protocol ID
- NFEC-2022-309
- Status last verified
- Sep 2023
- First submitted
- 18 Sep 2023
- Last updated
- 28 Sep 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Shen X, Li FT, Quan Cheng Y, Zheng MH, Yao XQ, Wang HM, Ting Chen J, Jiang H. Comparison of a novel hand-held retractor-assisted transforaminal lumbar interbody fusion by the wiltse approach and posterior TLIF: a one-year prospective controlled study. BMC Musculoskelet Disord. 2024 Feb 14;25(1):142. doi: 10.1186/s12891-024-07248-w.
PubMed 38355528
Study at a glance
From the registry record, last updated by the sponsor on 28 Sep 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Controlled Study of Articular Process Retractor Assisted- Multifidus Lateral Approach for Transforaminal Lumbar Interbody Fusion
- ClinicalTrials.gov ID
- NCT06052579
- Acronym / sponsor ID
- NFEC-2022-309
- Conditions
- Lumbar Stenosis, Spondylolisthesis
- Keywords
- Wiltse approach TLIF, transforaminal lumbar interbody fusion, hand-held retractors system
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Nanfang Hospital, Southern Medical UniversityUniversity, hospital or other
- Study start
- 1 Jan 2019 (actual)
- Primary completion
- 1 Dec 2021 (actual)
- Study completion
- 30 Jun 2023 (actual)
- First posted
- 25 Sep 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In recent years, hand-held retractors have been applied to assist in Wiltse approach to perform canal decompression, causing less paraspinal muscle injury and yielding better postoperative clinical outcomes than P-TLIF. However, few prospective studies have been conducted comparing the clinical and radiological outcomes between Wiltse TLIF and P-TLIF, both assisted by hand-held retractors. Therefore, further research is warranted to assess whether hand-held retractor-assisted Wiltse TLIF can yield less paraspinal muscle injury and better postoperative clinical outcomes.
Detailed description
Study procedures How many people will participate in this study? Approximately 60 people will participate in this study conducted at the Nanfang Hospital of Southern Medical University.
Research Steps ■ Pre-study:
To determine if you are eligible to participate, the following procedures will be conducted during the screening:
Obtain your demographic and vital sign information Perform a physical examination Inquire about your medical history and concurrent medications Collect blood and urine samples for laboratory testing, imaging (X-ray, CT, MRI) If you are a fertile female, a pregnancy test will be conducted. A negative result is required for your participation in this study.
The screening results and/or results of relevant issues will help the researchers decide if you can continue with this study. If these checks indicate that you are suitable for this study, you will be informed by the researchers to proceed to visit 2 as soon as possible. If you do not meet the relevant criteria, you cannot continue to participate in this study, and the results will be communicated to you promptly.
■ Baseline Phase
If the researchers confirm that you meet the criteria for joining this trial, you will be enrolled in this study and undergo a transforaminal lumbar interbody fusion (TLIF) through either a multilevel paraspinal approach or a posterior midline approach, which will be randomly allocated (similar to drawing lots). The following procedures will be conducted during this visit:
Reconfirm your eligibility for participation Allocate you to either the multilevel paraspinal group or the posterior midline group based on randomization Conduct a physical examination and collect vital sign data Preoperative visual analog scale (VAS) score for pain, Oswestry Disability Index (ODI) score for back pain, Japanese Orthopaedic Association (JOA) score for lower back pain, and MOS 36-Item Short Form Health Survey (SF-36) quality of life score ■ Treatment Phase
During this period, the researchers will perform surgery on you based on the randomization results and assess the surgical outcomes. To ensure the accurate recording and evaluation of your condition, your cooperation is required for the following procedures:
Record postoperative drainage, time to get out of bed, discharge time, and postoperative complications Extract approximately 5ml of venous blood from you 24 hours after surgery to measure serum creatine kinase (CK) and C-reactive protein (CRP) Assess you using the VAS, ODI, JOA lower back pain score, and SF-36 quality of life score 7 days after surgery
■ Follow-up Phase
After you complete this stage of visits, it is generally considered that you have completed the entire study. The following procedures will be carried out during this period:
X-ray examination of the lumbar vertebrae in the anteroposterior and lateral views, assessment of pain, functional impairment, and quality of life score at the 3rd month after surgery X-ray and lumbar spine MRI at the 6th month after surgery, assessment of pain, functional impairment, and quality of life score X-ray and lumbar spine CT at the 1st year after surgery, assessment of pain, functional impairment, and quality of life score X-ray and lumbar spine CT at the 2nd year after surgery, assessment of pain, functional impairment, and quality of life score 3.3. What tests and assessments will be conducted in this study? After providing written informed consent, you will undergo various tests, examinations, and procedures during this study. If you have any concerns about any of these tests, please discuss them with the study doctor.
Regarding the tests and procedures for this study, we would like to provide the following information:
Medical history: The study doctor will ask you some questions to understand any current or past illnesses.
Demographic data: The study doctor will collect personal information about you, such as date of birth and ethnic background.
Physical examination: The study doctor will conduct a medical examination of your body to assess all or part of the following human body systems: head, eyes, ears, nose and throat, chest, lungs, heart, abdomen, bones, skin, neck, and nervous system.
Height and weight: Your height and weight will be measured. Vital signs: The study doctor will measure your blood pressure, heart rate, body temperature, and respiratory rate.
Blood collection: During this study, you will undergo multiple blood draws. Blood samples will be collected for the following purposes:
Preoperative blood draw: Preoperative tests (complete blood count, electrolytes, liver and kidney function, coagulation function, infection indicators), routine preoperative assessment.
Blood draw 24 hours after surgery: Approximately 5ml of venous blood will be drawn to measure serum creatine kinase (CK) and C-reactive protein (CRP).
Routine blood tests on the 3rd day after surgery: Complete blood count, ion six tests, infection two tests.
Urine samples: Routine urine tests. Pulmonary function and echocardiography if necessary. Lumbar spine anteroposterior (preoperative, 7 days after surgery, 3 months after surgery, 6 months after surgery, 1 year after surgery, 2 years after surgery), dynamic positions, oblique positions, lumbar spine MRI (preoperative and 6 months after surgery), lumbar spine CT (preoperative, 1 year after surgery, 2 years after surgery).
Questionnaire: Visual Analog Scale (VAS) score for pain, Oswestry Disability Index (ODI) score for back pain, Japanese Orthopaedic Association (JOA) score for lower back pain, and MOS 36-Item Short Form Health Survey (SF-36) quality of life score (preoperative, 7 days after surgery, 3 months after surgery, 6 months after surgery, 1 year after surgery, 2 years after surgery) How long will this study last? This clinical study will last approximately 2 years (6 visits in total). During your participation in this study, you must comply with the specified visit schedule.
You have the right to control the use and disclosure of your personal information. Where permitted by national law, you can request to view your medical information at any time. You have the right to review all information collected about you in this study and request corrections (if applicable).
New information related to the study During the study period, if there are changes in study procedures, newly discovered side effects, or significant developments that may affect your health or willingness to participate, the research team will inform you. The study doctor will notify you immediately and discuss with you whether you want to continue participating in this study. If you decide not to continue in this study, the study doctor will make arrangements for your diagnostic and therapeutic care to continue. If you choose to remain in this study, the study doctor may ask you to sign a new informed consent form.
Use of Research Results and Confidentiality of Personal Information At the end of the study, we will prepare a report and send it to the government regulatory agency. The results of this study may also be published in journals or presented at conferences, but will not contain any information that could identify you. To ensure privacy, records or samples published for research purposes will not include your name or other identifying information. Instead, your information will be identified only by a code. Only the study doctor and authorized personnel will be able to link this code to your name using a list that will be securely kept at the study center. In order to ensure that the study is conducted correctly at the study center, when necessary, the applicant, the ethics review committee, and the government regulatory authorities may review your information according to regulations. They are bound by confidentiality and will not violate your privacy.
You have the right to control the use and disclosure of your personal information. Where permitted by national law, you can request to view your medical information. You have the right to review all information collected about you in this study and request corrections (if applicable).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- This one-year prospective controlled study compared two approaches (Wiltse TLIF vs P-TLIF) for hand-held retractors-assisted TLIF was approved by the Institutional Review Board (IRB) of our hospital. Written informed consent was obtained from all study participants. 60 eligible patients were included in this study and were divided into two groups.30patientswere included in the study group and underwent Wiltse TLIF, and 30 were included in the control group and underwent P-TLIF.
| Arm | Type | Receives |
|---|---|---|
| study group | Experimental | Procedure: new hand-held retractor systems-assisted WiltseTLIF surgerythe patients included in the study group underwent Wiltse TLIF |
| control group | Active comparator | Procedure: new hand-held retractor systems-assisted WiltseTLIF surgerythe patients included in the control group underwent traditional posterior -TLIF |
Who may qualify
- Ages
- 20 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- patients underwent either one or two-level spinal fusion surgery due to lumbar stenosis, grade 1 or 2 spondylolisthesis, or lumbar disc herniation with lumbar instability and mechanical lower back pain
Key exclusion criteria (1 listed)
- Patients with lumbar infection (i), spinal tumor (ii), severe osteoporosis (iii), pregnant and lactating women (iv), severe lumbar stenosis (v), and severe comorbidities (vi)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| new hand-held retractor systems-assisted WiltseTLIF surgerypatients were included in study group underwent the new hand-held retractors assisted Wiltse TLIF surgery | Procedure or surgery | control group, study group |
Primary outcome
the degree of paraspinal muscle degeneration
Time frame: 6 months postoperatively
the infiltration of fat and connective tissue are mainly manifested as enhanced signals on T2-weighted imaging
1 secondary outcome
the degree of paraspinal muscle degeneration
Time frame: Preoperative,7 days, 3, 6, and 12 months after surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Sep 2023.
- Derived from this study: PubMed 38355528Shen X, Li FT, Quan Cheng Y, Zheng MH, Yao XQ, Wang HM, Ting Chen J, Jiang H. Comparison of a novel hand-held retractor-assisted transforaminal lumbar interbody fusion by the wiltse approach and posterior TLIF: a one-year prospective controlled study. BMC Musculoskelet Disord. 2024 Feb 14;25(1):142. doi: 10.1186/s12891-024-07248-w.
- Individual participant dataSharing planned: No
Related trials for Lumbar Stenosis
Not yet recruitingObservational study
Foraminal Imaging and Symptoms in Single-Level Degenerative Lumbar Stenosis
Degenerative Lumbar Spinal Stenosis, Lumbar Foraminal Stenosis
Recruiting
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device
Degenerative Conditions of the Lumbar Spine, Lumbar Spinal Stenosis
RecruitingObservational study
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
RecruitingObservational study
Thoracic-Lumbar Arthrodesis- Implanet Jazz
Spondylolisthesis, Spinal Stenosis
Recruiting
Surgical Treatment of Adjacent Segment Stenosis
Adjacent Segment Disease, Lumbar Spinal Stenosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Xing Shen, M.D principal investigator
Nanfang Hospital, Southern Medical University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing new hand-held retractor systems-assisted WiltseTLIF surgery in people with Lumbar Stenosis and Spondylolisthesis, run by Nanfang Hospital, Southern Medical University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
the degree of paraspinal muscle degeneration (time frame: 6 months postoperatively). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06052579, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2023.